DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INDACATEROL MALEATE

« Back to Dashboard

Clinical Trials for Indacaterol Maleate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00396604	Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)	Completed	Novartis	Phase 2/Phase 3	The study is designed to obtain safety and efficacy data on three dose levels of indacaterol when delivered via an SDDPI in patients with COPD. All patients will receive 1 day of treatment with each of the following: indacaterol 150 µg, once- indacaterol 300 µg, indacaterol 600 µg, placebo, and formoterol. Each treatment day will be followed by a washout-period of 1 week.
NCT00403637	Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma	Completed	Novartis	Phase 2/Phase 3	The study is designed to obtain safety and efficacy data on three dose levels of indacaterol when delivered via an SDDPI in patients with persistent asthma. All patients will receive 1 day of treatment with each of the following: indacaterol 150 µg, indacaterol 300 µg, indacaterol 600 µg, placebo, and formoterol. Each treatment day will be followed by a washout-period of 1 week
NCT00556673	Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma	Completed	Merck Sharp & Dohme Corp.	Phase 2	This study is designed to evaluate the bronchodilatory efficacy of indacaterol maleate 500 μg/mometasone furoate 400 μg via the Twisthaler® device in adult patients with persistent asthma.

Clinical Trial Conditions for Indacaterol Maleate

Condition Name

Condition Name for Indacaterol Maleate
Intervention	Trials
Asthma	9
COPD	6
Chronic Obstructive Pulmonary Disease (COPD)	5

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Indacaterol Maleate
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	10
Lung Diseases	9
Asthma	9

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Indacaterol Maleate

Trials by Country

Trials by Country for Indacaterol Maleate
Location	Trials
United States	102
Italy	61
Spain	33
United Kingdom	27
Germany	19

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Indacaterol Maleate
Location	Trials
North Carolina	7
Texas	6
Florida	5
California	5
New Jersey	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Indacaterol Maleate

Clinical Trial Phase

Clinical Trial Phase for Indacaterol Maleate
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	5
Phase 2/Phase 3	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Indacaterol Maleate
Clinical Trial Phase	Trials
Completed	18
Recruiting	4
Terminated	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Indacaterol Maleate

Sponsor Name

Sponsor Name for Indacaterol Maleate
Sponsor	Trials
Novartis Pharmaceuticals	15
Novartis	6
Fondazione Salvatore Maugeri	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Indacaterol Maleate
Sponsor	Trials
Industry	24
Other	4

Export unavailable in trial.
Subscribe for complete access.